Apimeds Pharmaceuticals Appoints Sungjoon Chae Co-CEO, Effective May 4

Benzinga Newsdesk www.benzinga.com Neutral 93.3%

Neg 0% Neu 93.3% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1894525/000121390026052036/ea0289213-8k_apimeds.htm

Comments

No comments yet. Be the first!